The W Fund Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 19

- Investments
- 29
- Portfolio
- 9
- Exits
- 11

The W Fund General Information
Description
The W Fund is an early-stage venture capital firm that seeks to invest in technology-based firms operating in the life sciences, medical device, software, information technology, engineering, material and clean technology sectors. It seeks to invest in firms spinning out from the University of Washington and other research institutions. The firm was founded in 2012 and is based in Seattle, Washington.
Contact Information
Website
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- P.O. Box 95259
- Seattle, WA 98145
- United States
+1 (206) 000-0000
The W Fund Investments (29)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
FORTË | 15-Oct-2020 | Seed Round | Educational and Training Services (B2C) | Generating Revenue | ||
0000000 | 11-Jun-2020 | 00000 00000 | 00.00 | Electrical Equipment | Generating Revenue | |
0000000 | 20-Aug-2019 | 00000 00000 | 00.000 | Electrical Equipment | Generating Revenue | |
00000 | 02-Aug-2018 | 00000 00000 | 000.00 | Recreational Goods | Generating Revenue | 00000 000000 |
000000 000000 | 13-Oct-2017 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 00000 0000000000 00 |
0000000000 0000000 | 13-Sep-2017 | 0000 00000 | 00.00 | Biotechnology | Generating Revenue | 0000 00000 00. |
00000 000000000000 | 27-Jul-2017 | 00000 00000 | 00.000 | Other Healthcare Technology Systems | Generating Revenue | |
0000000 | 07-Mar-2017 | 0000 00000 | 00.00 | Electrical Equipment | Generating Revenue | |
Cyrus Biotechnology | 17-Feb-2017 | Seed Round | 00.000 | Other Healthcare Technology Systems | Generating Revenue | |
Olis Robotics | 14-Feb-2017 | Early Stage VC | 00.000 | Business/Productivity Software | Generating Revenue |
The W Fund Exits (11)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Athira Pharma | 18-Sep-2020 | IPO | 00000 |
0000000000 | 23-Jun-2020 | 000000000000000000 | |
00000 | 31-Dec-2019 | 0000000000: 000000 | |
00000000 | 11-Dec-2019 | 000 00 00000000 | |
0000000000 000 | 24-Apr-2019 | 000000000000000000 | 0000 |
00000000 00000000 | 01-Mar-2019 | 000 00 00000000 | |
0-0000 | 05-Apr-2018 | 000000000000000000 | |
0000 0000000000000 | 31-Mar-2017 | 000 00 00000000 | |
LumiSands | 04-Jan-2016 | Out of Business | |
Mobisante | Secondary Transaction - Private |
The W Fund Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialThe W Fund Team (17)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Linden Rhoads JD | General Manager, Board Member & Investment Committee Member | 0 | 0 | 0 | Seattle, WA |
John Gardner Ph.D | Independent Director | Seattle, WA | |||
Jeffry Canin | Board Member & Investment Committee Member | 0 | 0 | 0 | Seattle, WA |
Kirk Washington | Investment Committee Member | 00 | 0 | 0 | Seattle, WA |
Patrick Ennis Ph.D | Investment Committee Member | 0 | 0 | 0 | Seattle, WA |
The W Fund Co-Investors (45)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
WRF Capital | 6 | 0 | 0 |
![]() |
![]() |
Alliance of Angels | 0 | 0 | 0 |
![]() |
![]() |
OrbiMed | 0 | 0 |
![]() |
![]() |
|
Trilogy Equity Partners | 0 | 0 | 0 |
![]() |
![]() |
Trinity Ventures | 0 | 0 |
![]() |
![]() |